In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China

Nouveau short-course therapy and morphism mapping for clinical pulmonary Mycobacterium kansasii

(2021) Shashikant Srivastava et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China

(2021) Shu’an Wen et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Tedizolid: new data and experiences for clinical practice

(2021) Miguel Salavert Lletí et al.   Revista Espanola de Quimioterapia

Non-tuberculous mycobacterial pulmonary disease

(2019) Steven Cowman et al.   EUROPEAN RESPIRATORY JOURNAL

An overview of new antitubercular drugs, drug candidates, and their targets

(2019) Aparna Bahuguna et al.   MEDICINAL RESEARCH REVIEWS

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?

(2019) Mike Marvin Ruth et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China

(2018) Zhaojing Zong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics, Pharmacodynamics, and Tolerability of Single-Dose Oral LCB01-0371, a Novel Oxazolidinone with Broad-Spectrum Activity, in Healthy Volunteers

(2018) Yong-Soon Cho et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of tedizolid against the Mycobacterium abscessus complex

(2018) Fabrice Compain et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Effect of food on the pharmacokinetic characteristics of a single oral dose of LCB01-0371, a novel oxazolidinone antibiotic

(2018) Jung Sunwoo et al.   Drug Design Development and Therapy

OUP accepted manuscript

(2018)   CLINICAL INFECTIOUS DISEASES

Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates

(2018) Su-Young Kim et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Mycobacterium aquiterrae sp. nov., a rapidly growing bacterium isolated from groundwater

(2017) Jae-Chan Lee et al.   INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY

Structural insights into species-specific features of the ribosome from the human pathogen Mycobacterium tuberculosis

(2017) Kailu Yang et al.   NUCLEIC ACIDS RESEARCH

Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones inMycobacterium tuberculosis

(2016) Nele Coeck et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The prevalence of non-tuberculous mycobacterial infections in mainland China: Systematic review and meta-analysis

(2016) Xia Yu et al.   JOURNAL OF INFECTION

Mutations within therplDGene of Linezolid-Nonsusceptible Streptococcus pneumoniae Strains Isolated in the United States

(2014) W. Dong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis

(2014) Robert S. Wallis et al.   PLoS One

rplCT460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains

(2012) Patrick Beckert et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis

(2010) Robert S. Wallis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY